695 related articles for article (PubMed ID: 16413643)
41. Final report of the addendum to the safety assessment of n-butyl alcohol as used in cosmetics.
McLain VC
Int J Toxicol; 2008; 27 Suppl 2():53-69. PubMed ID: 18830864
[TBL] [Abstract][Full Text] [Related]
42. Acute respiratory responses of the mouse to chlorine.
Morris JB; Wilkie WS; Shusterman DJ
Toxicol Sci; 2005 Feb; 83(2):380-7. PubMed ID: 15548641
[TBL] [Abstract][Full Text] [Related]
43. Behavioral evaluation of the irritant properties of formaldehyde.
Wood RW; Coleman JB
Toxicol Appl Pharmacol; 1995 Jan; 130(1):67-72. PubMed ID: 7839371
[TBL] [Abstract][Full Text] [Related]
44. Effects of endogenous formaldehyde in nasal tissues on inhaled formaldehyde dosimetry predictions in the rat, monkey, and human nasal passages.
Schroeter JD; Campbell J; Kimbell JS; Conolly RB; Clewell HJ; Andersen ME
Toxicol Sci; 2014 Apr; 138(2):412-24. PubMed ID: 24385418
[TBL] [Abstract][Full Text] [Related]
45. Sensitivity analysis of biologically motivated model for formaldehyde-induced respiratory cancer in humans.
Crump KS; Chen C; Fox JF; Van Landingham C; Subramaniam R
Ann Occup Hyg; 2008 Aug; 52(6):481-95. PubMed ID: 18628253
[TBL] [Abstract][Full Text] [Related]
46. Acute effects of 1-octen-3-ol, a microbial volatile organic compound (MVOC)--an experimental study.
Wålinder R; Ernstgård L; Norbäck D; Wieslander G; Johanson G
Toxicol Lett; 2008 Oct; 181(3):141-7. PubMed ID: 18706986
[TBL] [Abstract][Full Text] [Related]
47. Formaldehyde: integrating dosimetry, cytotoxicity, and genomics to understand dose-dependent transitions for an endogenous compound.
Andersen ME; Clewell HJ; Bermudez E; Dodd DE; Willson GA; Campbell JL; Thomas RS
Toxicol Sci; 2010 Dec; 118(2):716-31. PubMed ID: 20884683
[TBL] [Abstract][Full Text] [Related]
48. Comparative assessment of early acute lung injury in mice and rats exposed to 1,6-hexamethylene diisocyanate-polyisocyanate aerosols.
Pauluhn J
Toxicology; 2008 May; 247(1):33-45. PubMed ID: 18375034
[TBL] [Abstract][Full Text] [Related]
49. Acetone odor and irritation thresholds obtained from acetone-exposed factory workers and from control (occupationally unexposed) subjects.
Wysocki CJ; Dalton P; Brody MJ; Lawley HJ
Am Ind Hyg Assoc J; 1997 Oct; 58(10):704-12. PubMed ID: 9342830
[TBL] [Abstract][Full Text] [Related]
50. Acute effects of exposure to vapours of acetic acid in humans.
Ernstgård L; Iregren A; Sjögren B; Johanson G
Toxicol Lett; 2006 Aug; 165(1):22-30. PubMed ID: 16490326
[TBL] [Abstract][Full Text] [Related]
51. Sensory irritation potential of selected nasal tumorigens in the rat.
Gardner RJ; Burgess BA; Kennedy GL
Food Chem Toxicol; 1985 Jan; 23(1):87-92. PubMed ID: 4038687
[TBL] [Abstract][Full Text] [Related]
52. A strategy for the evaluation of sensory and pulmonary irritation due to chemical emissions from indoor sources.
Muller WJ; Schaeffer VH
J Air Waste Manag Assoc; 1996 Sep; 46(9):808-12. PubMed ID: 8806216
[TBL] [Abstract][Full Text] [Related]
53. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
54. Health risks associated with inhaled nasal toxicants.
Feron VJ; Arts JH; Kuper CF; Slootweg PJ; Woutersen RA
Crit Rev Toxicol; 2001 May; 31(3):313-47. PubMed ID: 11405443
[TBL] [Abstract][Full Text] [Related]
55. Transcriptomic analysis of F344 rat nasal epithelium suggests that the lack of carcinogenic response to glutaraldehyde is due to its greater toxicity compared to formaldehyde.
Hester SD; Barry WT; Zou F; Wolf DC
Toxicol Pathol; 2005; 33(4):415-24. PubMed ID: 16036858
[TBL] [Abstract][Full Text] [Related]
56. Final report on the safety assessment of Triethylene Glycol and PEG-4.
Int J Toxicol; 2006; 25 Suppl 2():121-38. PubMed ID: 17090481
[TBL] [Abstract][Full Text] [Related]
57. Two-year inhalation study of carcinogenicity and chronic toxicity of 1,4-dioxane in male rats.
Kasai T; Kano H; Umeda Y; Sasaki T; Ikawa N; Nishizawa T; Nagano K; Arito H; Nagashima H; Fukushima S
Inhal Toxicol; 2009 Sep; 21(11):889-97. PubMed ID: 19681729
[TBL] [Abstract][Full Text] [Related]
58. Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses.
Schlosser PM; Lilly PD; Conolly RB; Janszen DB; Kimbell JS
Risk Anal; 2003 Jun; 23(3):473-87. PubMed ID: 12836840
[TBL] [Abstract][Full Text] [Related]
59. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
60. Pharmacodynamics of formaldehyde: applications of a model for the arrest of DNA replication by DNA-protein cross-links.
Heck H; Casanova M
Toxicol Appl Pharmacol; 1999 Oct; 160(1):86-100. PubMed ID: 10502505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
